The FDA has issued a warning letter to Novo Nordisk for violating postmarketing adverse drug experience regulations that include failure to report adverse events among patients taking GLP-1s. In the ...

Removing the climate science chapter advances neither science nor the law. It only deprives judges of a resource needed to do their jobs.